A detailed history of Pnc Financial Services Group, Inc. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 10,013 shares of DVAX stock, worth $123,760. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,013
Previous 9,528 5.09%
Holding current value
$123,760
Previous $106,000 4.72%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$10.05 - $11.61 $4,874 - $5,630
485 Added 5.09%
10,013 $111,000
Q2 2024

Aug 09, 2024

BUY
$10.73 - $12.58 $28,348 - $33,236
2,642 Added 38.37%
9,528 $106,000
Q1 2024

May 10, 2024

SELL
$11.7 - $14.98 $1,848 - $2,366
-158 Reduced 2.24%
6,886 $85,000
Q4 2023

Feb 09, 2024

BUY
$13.09 - $14.98 $418 - $479
32 Added 0.46%
7,044 $98,000
Q3 2023

Nov 13, 2023

SELL
$12.64 - $14.99 $771 - $914
-61 Reduced 0.86%
7,012 $103,000
Q2 2023

Aug 11, 2023

SELL
$9.85 - $13.17 $8,313 - $11,115
-844 Reduced 10.66%
7,073 $91,000
Q1 2023

May 15, 2023

SELL
$9.44 - $11.88 $25,582 - $32,194
-2,710 Reduced 25.5%
7,917 $77,000
Q4 2022

Feb 10, 2023

BUY
$10.27 - $13.29 $79,736 - $103,183
7,764 Added 271.18%
10,627 $113,000
Q3 2022

Nov 10, 2022

SELL
$9.93 - $17.44 $39,451 - $69,289
-3,973 Reduced 58.12%
2,863 $29,000
Q2 2022

Aug 12, 2022

BUY
$7.45 - $12.83 $36,028 - $62,045
4,836 Added 241.8%
6,836 $86,000
Q1 2022

May 12, 2022

BUY
$9.75 - $14.44 $19,500 - $28,880
2,000 New
2,000 $21,000
Q4 2020

Feb 12, 2021

SELL
$3.73 - $5.6 $7,460 - $11,200
-2,000 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$4.32 - $11.7 $8,640 - $23,400
2,000 New
2,000 $8,000
Q1 2018

May 11, 2018

SELL
$14.65 - $19.9 $277,383 - $376,786
-18,934 Closed
0 $0
Q4 2017

Feb 09, 2018

SELL
$17.3 - $24.08 $163,225 - $227,194
-9,435 Reduced 33.26%
18,934 $0
Q3 2017

Nov 13, 2017

BUY
$15.2 - $21.5 $431,208 - $609,933
28,369
28,369 $0

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.56B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.